PRMT3 and hepatocellular carcinoma: Furthermore, as a proof‐of‐concept, our work has also shown the effectiveness of combining PRMT3 inhibitor and oligomycin in suppressing HCC growth in a subset of HCC patients with high PRMT3 expression.